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A B S T R A C T
We present the case of a 63-year-old woman presenting with a huge pelvic and retroperitoneal high
ﬂow arteriovenous malformation (AVM) causing high-output heart failure, who was treated with
combined therapies, including transarterial embolization with n-butyl cyanoacrylate–iodized oil
mixture (NBCA–lip) and coils for the right ovarian, both internal iliac, 3rd and 4th lumber arteries,
venous sclerotherapy using coils and ethanolamine oleate (EO) for the right ovarian and both internal
iliac veins with balloon-occluded retrograde transvenous obliteration technique, and direct
percutaneous sclerotherapy using the NBCA–lip and EO for the large nidus of AVM under outﬂow
control using occlusion balloon catheters.
<Learning objective: Huge arteriovenous ﬁstulae or malformation (AVF/M) are potentially life
threatening due to the potential for spontaneous hemorrhaging and high-output heart failure and are
notoriously difﬁcult to diagnose and treat. To improve the high-output heart failure, intensive and
invasive combined treatments for huge AVF/M are needed including transarterial and transvenous
embolization and sclerotherapy and percutaneous nidus sclerotherapy.>
 2015 Japanese College of Cardiology. Published by Elsevier Ltd. All rights reserved.
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Arteriovenous ﬁstulae or malformation (AVF/M) that cause
heart failure commonly occur due to congenital, post-traumatic,
or iatrogenic disorders [1–3]. The etiology of AVF/M causing heart
failure is usually congenital AVM, post-traumatic vascular
injuries, or iatrogenic complications after catheterization or
surgery [1–3]. The symptoms of AVF following trauma or surgical
complications typically develop soon after the vascular injury.
Several cases of surgical and interventional treatments of high
ﬂow AVMs in the liver have been reported. In the late 1970s,
surgical arterial ligation was the sole method of treatment and
ligation of the common hepatic artery was carried out for the
patients with large hepatic AVM to reduce large left-to-right
shunts [4]. In the patients initially treated with transarterial* Corresponding author at: Department of Radiology, Yamaguchi University,
Graduate School of Medicine, 1-1-1 Minamikogushi, Ube, Yamaguchi 755-8505,
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collateral circulation did not improve the symptoms [5]; however,
the effects have varied. In this case, we treated a high-output heart
failure woman with the hybrid therapy of TAE, balloon-occluded
retrograde transvenous obliteration (B-RTO), and direct percuta-
neous sclerotherapy under outﬂow control using large occlusion
balloon catheters.
Case report
A 63-year-old woman suffered from high-output heart failure
caused by huge left peritoneal and right-sided pelvic AVMs. The
patient was 152 cm tall and weighed 51 kg; her blood pressure
was 119/69 mmHg and heart rate was 92 beats/min. She had
undergone hysterectomy 18 years prior due to uterine myoma;
she had also undergone resection of right atrial and lung tumors
11 years previously due to intravenous leiomyomatosis (IVL) that
extended into the right atrium and lung via the inferior vena cava
(IVC). Hormone therapy was applied for two years after the
resection of the atrial and lung tumors. However, stent grafts
were placed to reduce the high-output heart failure caused bys reserved.
Fig. 1.
Initial chest X-ray and computed tomography (CT). A chest X-ray showed cardiomegaly with dilated pulmonary arteries, suggesting congestive heart failure (A).
The contrast-enhanced CT shows hypervascular lesions in the left retroperitoneum and right-sided pelvis with numerous meandering and dilated arteries, dilated
left renal vein, right ovarian vein, and both bilateral iliac veins (B).
M. Okada et al. / Journal of Cardiology Cases 12 (2015) 162–165 163high ﬂow pelvic AVM two years previously. A main body
Powerlink stentgraft (25  55 mm; Endologix Inc., Irvine, CA,
USA) was placed to reduce the inferior mesenteric arterial ﬂow
and a Zenith leg stentgraft (Cook Japan, Tokyo, Japan) was placed
to reduce the right internal iliac arterial ﬂow into pelvic AVM but
was unsuccessful. The patient was admitted to our hospital, and
echocardiography showed normal left ventricular (LV) function
(ejection fraction: 67%, diastolic LV diameter: 55 mm) with
pulmonary hypertension (estimated pulmonary arterial pres-
sure: 60 mmHg). The pulse oximetry was 97% under room air and
an electrocardiogram showed tachycardia (111 beats/min) and a
complete right bundle branch block. A blood examination
showed elevated initial B-type natriuretic peptide level (BNP:
587.2 pg/ml), total bilirubin (2.1 mg/dl), creatinine (1.06 mg/dl),
blood urea nitrogen (30 mg/dl), which may have been associated
with the high-output heart failure.
A chest X-ray showed cardiomegaly with dilated pulmonary
arteries, suggesting congestive heart failure, and sternal wire was
placed at the resection of the atrial tumor (Fig. 1A). On contrast-
enhanced computed tomography (CT), numerous meandering
vessels were noted at the right pelvis and left retroperitoneum
with an aneurysmal-dilated left renal vein (Fig. 1B).
Doppler ultrasound showed the pulse wave in the infrarenal
IVC and laminar ﬂow along the left renal vein. The pelvic AVM
was speculated to affect the high-output heart failure more
seriously than the left retroperitoneal AVM. To reduce the high-
output ﬂow from the pelvic AVM, TAE and nidus sclerotherapy
under outﬂow control were necessary. Celiac, superior mesen-
teric, both renal, left internal iliac, right ovarian, and lumbar
arteriographies were performed to conﬁrm the feeding vessels to
the AVMs. The right ovarian artery and left internal iliac arteries
were main feeders for the pelvic AVM. To protect the pulmonary
emboli caused by high venous returns through the AVM canals,
occlusion balloons were placed in the right ovarian using a
Selecon MP catheter with a 13 mm balloon diameter (Terumo
Clinical Supply Co., Ltd., Gifu, Japan) and bilateral internal iliacveins using two TMP lock-balloon catheters (Tokai Medical
Products Inc., Aichi, Japan) via the transjugular approach
(Fig. 2A). Two Selecon MP catheters with a 9 mm balloon
diameter were also used for the inﬂow controls and n-butyl
cyanoacrylate–iodized oil mixture (NBCA–lip, NBCA:lipio-
dol = 1:7–8) and 0.035 inch Tornado microcoils (Cook Japan)
ranging from 3 to 8 mm in diameter were used as embolic agents.
The pelvic AVM nidus was directly punctured under CT guidance
and sclerotherapeutic agents of 5% monoethanolamine oleate
(EO: Fuji Chemical Industry Co., Ltd., Toyama, Japan) and
0.035 inch Tornado coils with 10 mm diameter (Cook Japan)
were percutaneously inserted through this puncture needle.
After this ﬁrst session, the patient’s dyspnea improved and the
BNP level also decreased from 587.2 to 94.9 pg/ml, so she was
discharged from our hospital.
Two months after the ﬁrst session, congestive heart failure
aggravated dyspnea again and she was rehospitalized. Contrast-
enhanced CT showed the recanalization of the right internal iliac
artery which had been occluded with stent grafts, and BNP also
increased to 412.2 pg/ml. A second procedure was carried out in
the same manner as the ﬁrst session with outﬂow occlusion
balloons in both internal iliac veins. The recanalized right internal
iliac artery (Fig. 2B) was embolized with the NBCA–lip and
0.035 inch metallic coils ranging from 8 to 10 mm in diameter
under ﬂow-guidance using a Selecon MP catheter with a 9 mm
balloon. The pelvic AVM nidus was also directly punctured through
the right hip under CT guidance, and sclerotherapy was also
performed using the NBCA–lip and 5% EO after additional coil
deployment. After hybrid therapy, the right common iliac
arteriography showed complete occlusion of the recanalized right
internal iliac artery (Fig. 2C).
Minor pulmonary embolism occurred despite outﬂow control
during the second procedure. However, the BNP gradually
decreased and the patient was discharged one month after the
second procedure (Fig. 3). The patient is currently being followed
every two or three months in the outpatient clinic.
Fig. 2.
Embolization using occlusion-balloon catheters. Venous occlusion-balloon catheters were placed in the right ovarian and bilateral internal iliac veins and two
arterial occlusion-balloon catheters were also placed in both internal iliac arteries to control the high-output ﬂow from the pelvic arteriovenous malformation
(A). Right common iliac arteriography shows the recanalized right internal iliac artery with the dilated and meandering branches (B), and these recanalized
arteries were also embolized using metallic coil and n-butyl cyanoacrylate–iodized oil (lipiodol) mixture. After hybrid therapy, the right common iliac
arteriography shows the complete embolization of right recanalized internal iliac artery (C).
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AVF/Ms that cause heart failure are typically congenital, post-
traumatic vascular injuries, or iatrogenic disorders after catheteri-
zation or surgery [1–3]. Pelvic AVF/Ms are rare vascular lesions and
are notoriously difﬁcult to diagnose and treat [6]. Pelvic AVF/Ms
are potentially life threatening due to the potential for spontane-
ous hemorrhaging and high-output heart failure [7]. Our patient
had undergone hysterectomy because of uterine IVL, and this
tumor is a rare neoplasm characterized by invasion of the venous
channels by a benign smooth muscle tumor originating from a
uterine myoma or vessel wall [7]. IVL extends into the gonadal or
iliac veins to the vena cava and right atrium and may cause the
symptoms of congestive heart failure, eventually leading to a fatal
outcome. CT and angiography characteristically demonstrate a
hypervascular tumor.
The patients with high-output heart failure caused by AVF/M
have been treated with various techniques, including TAE [6] and
the placement of stent grafts with sclerotherapy [8]. In the present
case, transarterial and percutaneous direct-puncture embolization
and sclerotherapy were performed using the NBCA–lip and
metallic coils under nidus ﬂow control with transarterial andtransvenous occlusion balloons, and this hybrid therapy resulted in
the improvement of congestive heart failure. The NBCA–lip is
feasibly used for the embolization of the spinal dural AVF [9] and
direct-puncture embolization with the NBCA–lip also apply to
preoperative devascularization of craniofacial AVM as an effective
and safe technique [10]. For safe and effective embolization, the
compression of draining venous channels is important because
symptomatic pulmonary complications may occur after injection
of the NBCA–lip, particularly when delivery systems without ﬂow
arrest are used in high-ﬂow vascular brain lesions [10]. Thus, in the
present case, we occluded the feeding arteries and draining veins
using the occlusion balloon catheters. The complete embolization
or sclerotherapy of huge AVM is sometimes difﬁcult, but it is
impossible to discontinue the procedure once it is started, because
insufﬁcient embolization may cause pulmonary embolism and
worsen the symptoms of pulmonary congestion. The repeated
embolization and sclerotherapy for the pelvic AVM were
completed to improve the symptoms of high-output heart failure
in the present case.
The combined therapy using transcatheter and percutaneous
direct-puncture embolization and sclerotherapy with the B-RTO
technique was needed for reducing the high ﬂow shunt of a huge
Fig. 3.
Clinical course after treatment. After ﬁrst intervention, B-type natriuretic peptide (BNP) level rapidly decreased, but soon increased due to the recanalization of
the right internal iliac artery. However, BNP gradually decreased after second treatment.
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caused by high-output heart failure.
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